99mTc-PSMA-I&Amp;S in Patients With Prostate Cancer: An Exploratory Biodistribution Study With Histopathology Validation
Condition: Prostate Carcinoma, Recurrent Prostate Carcinoma
Study Type: Interventional
Clinical Trials Identifier NCT 8-digits: NCT04857502
Sponsor: Jonsson Comprehensive Cancer Center
Phase: Early Phase 1
Eligibility:
- Age: minimum N/A maximum N/A
- Gender: Male
Inclusion Criteria:
- Men with PCa (primary or recurrent disease)
- Men who received a 68Ga-PSMA-11 positron emission tomography (PET)/computed tomography (CT) for staging or restaging
- Men with evidence of lymph nodes (LNs)-positive disease on 68Ga-PSMA-11 PET/CT
- Men who are scheduled for pelvic LN dissection (PLND)
- Men who can provide oral and written informed consent
- Men who can comply with study procedures
Exclusion Criteria:
- Patients who started any PCa treatment between study enrollment and surgery
- Technically inaccessible nodal location
View trial on ClinicalTrials.gov